MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy

American Journal of Pathology

Volumn 179, Issue 2, 2011, Pages 639-650

  Shen, E ^a,b   Diao, Xuehong ^a   Wang, Xiaoxia ^a   Chen, Ruizhen ^c   Hu, Bing ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Institute of Ultrasound in Medicine   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; COLLAGEN FIBRIL; CYTOSKELETON PROTEIN; GLUCOSE; GUANOSINE TRIPHOSPHATASE; INSULIN RECEPTOR; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; RAS PROTEIN; RHO FACTOR; SOMATOMEDIN RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; CELL SIZE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; ENZYME INHIBITION; GENE EXPRESSION; GENE TARGETING; HEART; HEART CONTRACTION; HEART DEVELOPMENT; HEART VENTRICLE HYPERTROPHY; HYPERGLYCEMIA; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE ADHERENCE; MALE; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CELLS, CULTURED; GLUCOSE; HYPERTROPHY; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICRORNAS; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 80052457747     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.04.034     Document Type: Article

References (47)

1. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
2. R.H. Plasterk Micro RNAs in animal development Cell 124 2006 877 881 (Pubitemid 43344225)
3. E. van Rooij, and E.N. Olson MicroRNAs: Powerful new regulators of heart disease and provocative therapeutic targets J Clin Invest 117 2007 2369 2376 (Pubitemid 47494334)
4. V. Divakaran, and D.L. Mann The emerging role of microRNAs in cardiac remodeling and heart failure Circ Res 103 2008 1072 1083
5. S. Hu, M. Huang, Z. Li, F. Jia, Z. Ghosh, M.A. Lijkwan, P. Fasanaro, N. Sun, X. Wang, F. Martelli, R.C. Robbins, and J.C. Wu MicroRNA-210 as a novel therapy for treatment of ischemic heart disease Circulation 122 2010 S124 S131
6. E. van Rooij, L.B. Sutherland, J.E. Thatcher, J.M. DiMaio, R.H. Naseem, W.S. Marshall, J.A. Hill, and E.N. Olson Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis Proc Natl Acad Sci USA 105 2008 13027 13032
7. B. Yang, H. Lin, J. Xiao, Y. Lu, X. Luo, B. Li, Y. Zhang, C. Xu, Y. Bai, H. Wang, G. Chen, and Z. Wang The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 Nat Med 13 2007 486 491 (Pubitemid 46559834)
8. Y. Cheng, R. Ji, J. Yue, J. Yang, X. Liu, H. Chen, D.B. Dean, and C. Zhang MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play a role in cardiac hypertrophy? Am J Pathol 170 2007 1831 1840 (Pubitemid 47339258)
9. E. van Rooij, L.B. Sutherland, N. Liu, A.H. Williams, J. McAnally, R.D. Gerard, J.A. Richardson, and E.N. Olson A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure Proc Natl Acad Sci USA 103 2006 18255 18260 (Pubitemid 44871645)
10. S. Rubler, J. Dlugash, Y.Z. Yuceoglu, T. Kumral, A.W. Branwood, and A. Grishman New type of cardiomyopathy associated with diabetic glomerulosclerosis Am J Cardiol 30 1972 595 602
11. S.A. Hayat, B. Patel, R.S. Khattar, and R.A. Malik Diabetic cardiomyopathy: mechanisms, diagnosis and treatment Clin Sci (Lond) 107 2004 539 557 (Pubitemid 39627201)
12. K. Khavandi, A. Khavandi, O. Asghar, A. Greenstein, S. Withers, A.M. Heagerty, and R.A. Malik Diabetic cardiomyopathya distinct disease? Best Pract Res Clin Endocrinol Metab 23 2009 347 360
13. J. Li, H. Zhu, E. Shen, L. Wan, J.M. Arnold, and T. Peng Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes Diabetes 59 2010 2033 2042
14. B. Feng, S. Chen, J. Chiu, B. George, and S. Chakrabarti Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level Am J Physiol Endocrinol Metab 294 2008 E1119 E1126
15. W.W. Kuo, L.C. Chung, C.T. Liu, S.P. Wu, C.H. Kuo, F.J. Tsai, C.H. Tsai, M.C. Lu, C.Y. Huang, and S.D. Lee Effects of insulin replacement on cardiac apoptotic and survival pathways in streptozotocin-induced diabetic rats Cell Biochem Funct 27 2009 479 487
16. B. Feng, S. Chen, B. George, Q. Feng, and S. Chakrabarti miR133a regulates cardiomyocyte hypertrophy in diabetes Diabetes Metab Res Rev 26 2010 40 49
17. E. Shen, Y. Li, L. Shan, H. Zhu, Q. Feng, J.M. Arnold, and T. Peng Rac1 is required for cardiomyocyte apoptosis during hyperglycemia Diabetes 58 2009 2386 2395
18. M.E. Barbosa, N. Alenina, and M. Bader Induction and analysis of cardiac hypertrophy in transgenic animal models Methods Mol Med 112 2005 339 352
19. Y. Zou, Y. Hiroi, H. Uozumi, E. Takimoto, H. Toko, W. Zhu, S. Kudoh, M. Mizukami, M. Shimoyama, F. Shibasaki, R. Nagai, Y. Yazaki, and I. Komuro Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy Circulation 104 2001 97 101 (Pubitemid 32623296)
20. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408 (Pubitemid 34164012)
21. L.T. Sam, E.A. Mendonca, J. Li, J. Blake, C. Friedman, and Y.A. Lussier PhenoGO: an integrated resource for the multiscale mining of clinical and biological data BMC Bioinformatics 10 Suppl 2 2009 S2 S8
22. D. Sayed, C. Hong, I.Y. Chen, J. Lypowy, and M. Abdellatif MicroRNAs play an essential role in the development of cardiac hypertrophy Circ Res 100 2007 416 424
23. T.E. Callis, K. Pandya, H.Y. Seok, R.H. Tang, M. Tatsuguchi, Z.P. Huang, J.F. Chen, Z. Deng, B. Gunn, J. Shumate, M.S. Willis, C.H. Selzman, and D.Z. Wang MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice J Clin Invest 119 2009 2772 2786
24. Z.Y. Fang, J.B. Prins, and T.H. Marwick Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications Endocr Rev 25 2004 543 567 (Pubitemid 39096070)
25. M.E. Dolan, L. Ni, E. Camon, and J.A. Blake A procedure for assessing GO annotation consistency Bioinformatics 21 Suppl 1 2005 i136 i143
26. S. Draghici, P. Khatri, A.L. Tarca, K. Amin, A. Done, C. Voichita, C. Georgescu, and R. Romero A systems biology approach for pathway level analysis Genome Res 17 2007 1537 1545 (Pubitemid 47529438)
27. M. Yi, J.D. Horton, J.C. Cohen, H.H. Hobbs, and R.M. Stephens WholePathwayScope: A comprehensive pathway-based analysis tool for high-throughput data BMC Bioinformatics 7 2006 1 24
28. M. Kanehisa, S. Goto, S. Kawashima, Y. Okuno, and M. Hattori The KEGG resource for deciphering the genome Nucleic Acids Res 32 2004 D277 D280
29. G. Esposito, S.V. Prasad, A. Rapacciuolo, L. Mao, W.J. Koch, and H.A. Rockman Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload Circulation 103 2001 1453 1458 (Pubitemid 32220640)
30. C. Ruwhof, and A. van der Laarse Mechanical stress-induced cardiac hypertrophy: Mechanisms and signal transduction pathways Cardiovasc Res 47 2000 23 37 (Pubitemid 30408547)
31. P. Malekar, M. Hagenmueller, A. Anyanwu, S. Buss, M.R. Streit, C.S. Weiss, D. Wolf, J. Riffel, A. Bauer, H.A. Katus, and S.E. Hardt Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling Hypertension 55 2010 939 945
32. T.G. Parker, S.E. Packer, and M.D. Schneider Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes J Clin Invest 85 1990 507 514 (Pubitemid 20070059)
33. N. Shimojo, S. Jesmin, S. Zaedi, T. Otsuki, S. Maeda, N. Yamaguchi, K. Aonuma, Y. Hattori, and T. Miyauchi Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy Am J Physiol Heart Circ Physiol 293 2007 H474 H481
34. J. Pan, K. Fukuda, H. Kodama, S. Makino, T. Takahashi, M. Sano, S. Hori, and S. Ogawa Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart Circ Res 81 1997 611 617 (Pubitemid 27432749)
35. J. Pan, K. Fukuda, H. Kodama, M. Sano, T. Takahashi, S. Makino, T. Kato, T. Manabe, S. Hori, and S. Ogawa Involvement of gp130-mediated signaling in pressure overload-induced activation of the JAK/STAT pathway in rodent heart Heart Vessels 13 1998 199 208 (Pubitemid 29322463)
36. J.R. McMullen, M.C. Sherwood, O. Tarnavski, L. Zhang, A.L. Dorfman, T. Shioi, and S. Izumo Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload Circulation 109 2004 3050 3055 (Pubitemid 38808328)
37. J.D. Molkentin, and G.W. Dorn 2nd Cytoplasmic signaling pathways that regulate cardiac hypertrophy Annu Rev Physiol 63 2001 391 426 (Pubitemid 32304323)
38. A.J. Muslin MAPK signalling in cardiovascular health and disease: Molecular mechanisms and therapeutic targets Clin Sci (Lond) 115 2008 203 218
39. T. Thum, C. Gross, J. Fiedler, T. Fischer, S. Kissler, M. Bussen, P. Galuppo, S. Just, W. Rottbauer, S. Frantz, M. Castoldi, J. Soutschek, V. Koteliansky, A. Rosenwald, M.A. Basson, J.D. Licht, J.T. Pena, S.H. Rouhanifard, M.U. Muckenthaler, T. Tuschl, G.R. Martin, J. Bauersachs, and S. Engelhardt MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts Nature 456 2008 980 984
40. G.R. Yan, S.H. Xu, Z.L. Tan, L. Liu, and Q.Y. He Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics Proteomics 11 2011 912 920
41. K. Yang, A.M. Handorean, and K.A. Iczkowski MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro Int J Clin Exp Pathol 2 2009 361 369
42. P.M. Voorhoeve, C. le Sage, M. Schrier, A.J. Gillis, H. Stoop, R. Nagel, Y.P. Liu, J. van Duijse, J. Drost, A. Griekspoor, E. Zlotorynski, N. Yabuta, G. De Vita, H. Nojima, L.H. Looijenga, and R. Agami A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors Cell 124 2006 1169 1181
43. K.H. Lee, Y.G. Goan, M. Hsiao, C.H. Lee, S.H. Jian, J.T. Lin, Y.L. Chen, and P.J. Lu MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer Exp Cell Res 315 2009 2529 2538
44. Y. Chen, W. Gao, J. Luo, R. Tian, H. Sun, and S. Zou Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma Oncol Rep 25 2010 443 451
45. S.M. Kolodziejczyk, L. Wang, K. Balazsi, Y. DeRepentigny, R. Kothary, and L.A. Megeney MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium Curr Biol 9 1999 1203 1206 (Pubitemid 29527110)
46. J. Han, and J.D. Molkentin Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology Trends Cardiovasc Med 10 2000 19 22 (Pubitemid 32012677)
47. H. Akazawa, and I. Komuro Roles of cardiac transcription factors in cardiac hypertrophy Circ Res 92 2003 1079 1088 (Pubitemid 36665853)